Literature DB >> 16965269

A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo.

Maria Lucia Dell'anna1, Mauro Picardo.   

Abstract

Vitiligo is an acquired depigmenting disorder characterized by the loss of functioning epidermal melanocytes because of multifactorial and overlapping pathogenetic mechanisms. Besides the immunological approach, the study of the metabolic deregulations leading to toxic damage of the melanocytes appears to be more and more relevant. It was only last year that the first in vitro evidence supporting the link and the temporal sequence between the immune response and the cellular oxidative stress was provided, suggesting that the intrinsic damage of the melanocytes is primitive. What can be the guide line of the multiple altered metabolisms? A compromised membrane could render the cell sensitive to the external and internal agents differently, usually ineffective on the cell activity and survival. The primitive altered arrangement of the lipids may affect the transmembrane housing of proteins with enzymatic or receptorial activities, also conferring on them antigenic properties.

Entities:  

Mesh:

Year:  2006        PMID: 16965269     DOI: 10.1111/j.1600-0749.2006.00333.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  25 in total

Review 1.  Melatonin membrane receptors in peripheral tissues: distribution and functions.

Authors:  Radomir M Slominski; Russel J Reiter; Natalia Schlabritz-Loutsevitch; Rennolds S Ostrom; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2012-01-08       Impact factor: 4.102

2.  Methotrexate for the treatment of generalized vitiligo.

Authors:  Khalid Alghamdi; Huma Khurrum
Journal:  Saudi Pharm J       Date:  2013-10       Impact factor: 4.330

3.  A New View of Vitiligo: Looking at Normal-Appearing Skin.

Authors:  Mauro Picardo; Emanuela Bastonini
Journal:  J Invest Dermatol       Date:  2015-07       Impact factor: 8.551

Review 4.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

5.  Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.

Authors:  Cheng Quan; Yun-Qing Ren; Lei-Hong Xiang; Liang-Dan Sun; Ai-E Xu; Xing-Hua Gao; Hong-Duo Chen; Xiong-Ming Pu; Ri-Na Wu; Chao-Zhao Liang; Jia-Bin Li; Tian-Wen Gao; Jian-Zhong Zhang; Xiu-Li Wang; Jun Wang; Rong-Ya Yang; Ling Liang; Jian-Bin Yu; Xian-Bo Zuo; Sheng-Quan Zhang; Shu-Mei Zhang; Gang Chen; Xiao-Dong Zheng; Pan Li; Jun Zhu; Yong-Wei Li; Xiao-Dong Wei; Wei-Song Hong; Ying Ye; Yong Zhang; Wei-Su Wu; Hui Cheng; Pu-Ling Dong; Da-Yan Hu; Yang Li; Min Li; Xin Zhang; Hua-Yang Tang; Xian-Fa Tang; Sheng-Xin Xu; Su-Min He; Yong-Mei Lv; Min Shen; Hong-Quan Jiang; Ying Wang; Kai Li; Xiao-Jing Kang; Yu-Qin Liu; Li Sun; Zhi-Fang Liu; Shao-Qiong Xie; Cheng-Yao Zhu; Qiang Xu; Jin-Ping Gao; Wen-Long Hu; Cheng Ni; Ting-Meng Pan; Yun Li; Sha Yao; Cai-Feng He; Yang-Sheng Liu; Ze-Ying Yu; Xian-Yong Yin; Feng-Yu Zhang; Sen Yang; Youwen Zhou; Xue-Jun Zhang
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

Review 6.  Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Authors:  Alexander B Dillon; Andrew Sideris; Ali Hadi; Nada Elbuluk
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

7.  Chemical Leukoderma Improved by Low-dose Steroid Pulse Therapy.

Authors:  Jae Yoon Jung; Kkot Bora Yeom; Hee Chul Eun
Journal:  Ann Dermatol       Date:  2010-05-19       Impact factor: 1.444

8.  [Vitiligo. What is new?].

Authors:  K U Schallreuter; M M A E L Salem
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

9.  Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.

Authors:  Mari-Anne Philips; Külli Kingo; Maire Karelson; Ranno Rätsep; Eerik Aunin; Ene Reimann; Paula Reemann; Orm Porosaar; Jonas Vikeså; Finn C Nielsen; Eero Vasar; Helgi Silm; Sulev Kõks
Journal:  BMC Med Genet       Date:  2010-04-08       Impact factor: 2.103

10.  Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP.

Authors:  Krassimira Ivanova; Britta Lambers; Rene van den Wijngaard; I Caroline Le Poole; Olga Grigorieva; Rupert Gerzer; Pranab K Das
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-07-02       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.